Q C Technologies Ord Shs
QCLS4.880USD
+0.520+11.93%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
14.53MMarket Cap
LossP/E TTM
More Details of Company
Q C Technologies Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Q C Technologies Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Stephen Friscia
Mr. Stephen Friscia
Independent Director
Independent Director
27.16K
+528.44%
Dr. Mitchell Glass, M.D.
Dr. Mitchell Glass, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
13.58K
+528.70%
Mr. Christopher C. Schreiber
Mr. Christopher C. Schreiber
Director
Director
30.00
+3.45%
Mr. Robert Schatz
Mr. Robert Schatz
Investor Relations
Investor Relations
--
--
Mr. Joshua N. (Josh) Silverman
Mr. Joshua N. (Josh) Silverman
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Ian Rhodes
Mr. Ian Rhodes
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Bruce Bernstein
Mr. Bruce Bernstein
Director
Director
--
--
Mr. Bill Joe White
Mr. Bill Joe White
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Stephen Friscia
Mr. Stephen Friscia
Independent Director
Independent Director
27.16K
+528.44%
Dr. Mitchell Glass, M.D.
Dr. Mitchell Glass, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
13.58K
+528.70%
Mr. Christopher C. Schreiber
Mr. Christopher C. Schreiber
Director
Director
30.00
+3.45%
Mr. Robert Schatz
Mr. Robert Schatz
Investor Relations
Investor Relations
--
--
Mr. Joshua N. (Josh) Silverman
Mr. Joshua N. (Josh) Silverman
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Ian Rhodes
Mr. Ian Rhodes
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Dec 9
Currency: USDUpdated: Tue, Dec 9
FY2019
By BusinessUSD
Name
Revenue
Proportion
Particle ImmunoFiltration Assay (“PIFA”)
1.33M
84.19%
MicroParticle Catalyzed Biosensor (“MPC”)
126.15K
8.00%
Rapid Enzymatic Assay (“REA”)
85.00K
5.39%
Other
38.13K
2.42%
By RegionUSD
Name
Revenue
Proportion
United States
1.56M
98.89%
Rest of the World
17.50K
1.11%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Particle ImmunoFiltration Assay (“PIFA”)
1.33M
84.19%
MicroParticle Catalyzed Biosensor (“MPC”)
126.15K
8.00%
Rapid Enzymatic Assay (“REA”)
85.00K
5.39%
Other
38.13K
2.42%
Shareholding Stats
Updated: Wed, Dec 10
Updated: Wed, Dec 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Silverman (Joshua)
2.61%
White (Billy Joe)
0.65%
Friscia (Stephen)
0.65%
Bernstein Bruce G
0.60%
Glass (Mitchell)
0.33%
Other
95.16%
Shareholders
Shareholders
Proportion
Silverman (Joshua)
2.61%
White (Billy Joe)
0.65%
Friscia (Stephen)
0.65%
Bernstein Bruce G
0.60%
Glass (Mitchell)
0.33%
Other
95.16%
Shareholder Types
Shareholders
Proportion
Individual Investor
5.14%
Investment Advisor
0.37%
Investment Advisor/Hedge Fund
0.14%
Hedge Fund
0.04%
Other
94.31%
Institutional Shareholding
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
69
22.85K
0.55%
+2.13K
2025Q3
77
16.99K
0.47%
+2.10K
2025Q2
83
5.39K
3.87%
-6.21K
2025Q1
79
4.88K
13.08%
-5.98K
2024Q4
85
4.17K
15.30%
-5.82K
2024Q3
86
442.00
1.99%
-9.58K
2024Q2
84
9.45K
43.70%
+7.33K
2024Q1
87
9.25K
42.96%
+6.52K
2023Q4
89
2.18K
12.83%
+182.00
2023Q3
91
1.43K
9.56%
-1.25K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Silverman (Joshua)
8.67K
0.42%
+8.64K
+28810.00%
Sep 18, 2025
White (Billy Joe)
2.19K
0.11%
+2.16K
+8640.00%
Sep 18, 2025
Friscia (Stephen)
2.16K
0.11%
+2.16K
--
Sep 18, 2025
Glass (Mitchell)
1.08K
0.05%
+1.08K
--
Sep 18, 2025
Fifth Lane Capital, LP
10.00K
0.24%
+10.00K
--
Sep 30, 2025
UBS Financial Services, Inc.
5.14K
0.12%
+4.49K
+690.15%
Sep 30, 2025
Tower Research Capital LLC
1.63K
0.04%
+1.58K
+3162.00%
Sep 30, 2025
View more
Related ETFs
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Name
Proportion
Cambria Cannabis ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Micro-Cap ETF
0%
Cambria Cannabis ETF
Proportion0%
Dimensional US Core Equity 1 ETF
Proportion0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Aug 28, 2025
Merger
100→1
Feb 13, 2024
Merger
30→1
Date
Type
Ratio
Aug 28, 2025
Merger
100→1
Feb 13, 2024
Merger
30→1
FAQs
Who are the top five shareholders of Q C Technologies Ord Shs?
The top five shareholders of Q C Technologies Ord Shs are:
Silverman (Joshua) holds 8.67K shares, accounting for 0.42% of the total shares.
White (Billy Joe) holds 2.19K shares, accounting for 0.11% of the total shares.
Friscia (Stephen) holds 2.16K shares, accounting for 0.11% of the total shares.
Glass (Mitchell) holds 1.08K shares, accounting for 0.05% of the total shares.
Fifth Lane Capital, LP holds 10.00K shares, accounting for 0.24% of the total shares.
Silverman (Joshua) holds 8.67K shares, accounting for 0.42% of the total shares.
White (Billy Joe) holds 2.19K shares, accounting for 0.11% of the total shares.
Friscia (Stephen) holds 2.16K shares, accounting for 0.11% of the total shares.
Glass (Mitchell) holds 1.08K shares, accounting for 0.05% of the total shares.
Fifth Lane Capital, LP holds 10.00K shares, accounting for 0.24% of the total shares.
What are the top three shareholder types of Q C Technologies Ord Shs?
The top three shareholder types of Q C Technologies Ord Shs are:
Silverman (Joshua)
White (Billy Joe)
Friscia (Stephen)
Silverman (Joshua)
White (Billy Joe)
Friscia (Stephen)
How many institutions hold shares of Q C Technologies Ord Shs (QCLS)?
As of 2025Q4, 69 institutions hold shares of Q C Technologies Ord Shs, with a combined market value of approximately 22.85K, accounting for 0.55% of the total shares. Compared to 2025Q3, institutional shareholding has increased by 0.08%.
What is the biggest source of revenue for Q C Technologies Ord Shs?
In FY2019, the Particle ImmunoFiltration Assay (“PIFA”) business generated the highest revenue for Q C Technologies Ord Shs, amounting to 1.33M and accounting for 84.19% of total revenue.
